AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,746,280 | +71.6% | 331,085 | +58.4% | 0.00% | +50.0% |
| Q2 2023 | $9,760,218 | +14.2% | 209,043 | -6.4% | 0.00% | 0.0% |
| Q1 2023 | $8,543,113 | -16.1% | 223,291 | +20.1% | 0.00% | 0.0% |
| Q4 2022 | $10,187,977 | -85.9% | 185,912 | -91.2% | 0.00% | -88.2% |
| Q3 2022 | $72,145,000 | +309.6% | 2,118,797 | +13.7% | 0.02% | +325.0% |
| Q2 2022 | $17,612,000 | +13.6% | 1,863,604 | +70.6% | 0.00% | +33.3% |
| Q1 2022 | $15,505,000 | -58.5% | 1,092,680 | -38.2% | 0.00% | -57.1% |
| Q4 2021 | $37,366,000 | +5261.0% | 1,766,714 | +5565.5% | 0.01% | – |
| Q3 2021 | $697,000 | -1.7% | 31,184 | +9.1% | 0.00% | – |
| Q2 2021 | $709,000 | -88.3% | 28,574 | -86.4% | 0.00% | -100.0% |
| Q1 2021 | $6,076,000 | -9.3% | 209,427 | -19.4% | 0.00% | 0.0% |
| Q4 2020 | $6,700,000 | +203.2% | 259,705 | +261.9% | 0.00% | +100.0% |
| Q3 2020 | $2,210,000 | +25.3% | 71,758 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $1,764,000 | +52.2% | 70,771 | +29.5% | 0.00% | – |
| Q1 2020 | $1,159,000 | +41.5% | 54,663 | +48.2% | 0.00% | – |
| Q4 2019 | $819,000 | +37.9% | 36,886 | +41.2% | 0.00% | – |
| Q3 2019 | $594,000 | -46.7% | 26,124 | -55.1% | 0.00% | – |
| Q2 2019 | $1,114,000 | – | 58,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |